13 results found.

Polymorphism-Genetic, Alcohol Drinking, Alcohol-Related Disorders Clinical Trial using OPRM1 AA118; Morphine; Placebo; OPRM1 GX118

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 55 years.
- OPRM1 A118G SNP Effect on Striatal Dopamine Response to an IV Opiate.
OPRM1 AA118; Morphine; Placebo; OPRM1 GX118

Alcohol-Related Disorders, Alcohol Dependence, Alcoholism, or Anx Clinical Trial using Pexacerfont; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 65 years.
- Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics.
Pexacerfont; Placebo

Alcohol Use Disorder Clinical Trial using Prazosin; Placebo

University of New Mexico - Recruiting 18 years to 65 years.
- .
Prazosin; Placebo

Alcohol Dependence, Alcohol Abuse, Alcohol Use Disorders, or Alco Clinical Trial using ABT-436; Matched Placebo - Sugar Pill

National Institute on Alcohol Abuse and Alcoholism (NIAAA) - Recruiting 21 years to 65 years.
- A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence.
ABT-436; Matched Placebo - Sugar Pill

Alcoholism, Alcohol-Related Disorders, Alcohol Dependence, Alcoho Clinical Trial using PF-05190457

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 65 years.
- A Novel Compound for Alcoholism Treatment: A Translational Strategy.
PF-05190457

Alcohol Dependence, Alcohol Drinking, Stress, or Alcohol-Related Clinical Trial using Pioglitazone; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 65 years.
- Role of Proinflammatory Signaling in Alcohol Craving.
Pioglitazone; Placebo

Alcohol Use Disorders Clinical Trial using Cognitive-behavioral treatment

State University of New York at Buffalo - Recruiting 18 years to 65 years.
- .
Cognitive-behavioral treatment

Alcohol Dependence, or Stress Disorders, Post-Traumatic Clinical Trial using Prazosin

Yale University - Recruiting 21 years to 65 years.
- The Use of Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD)..
Prazosin

Hepatitis C, or Alcohol Use Disorders Clinical Trial using baclofen; placebo

Department of Veterans Affairs - Recruiting 18 years or older.
- Efficacy & Safety of Baclofen to Reduce Alcohol Use in Veterans With HCV.
baclofen; placebo

HIV, Acquired Immunodeficiency Syndrome, Alcoholism, Alcoholic In Clinical Trial using Motivational Interviewing; Email Feedback; Usual Care

University of California, San Francisco - Recruiting 18 years or older.
- Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients.
Motivational Interviewing; Email Feedback; Usual Care

Bulimia Nervosa, or Alcohol Use Disorders Clinical Trial

New York State Psychiatric Institute - Recruiting 18 years to 45 years.
- Examining Common Substrates of Eating and Alcohol Use Disorders.

Alcohol Use Disorders, or Bipolar Disorder Clinical Trial using Zonisamide; Placebo

VA Connecticut Healthcare System - Recruiting 18 years to 65 years.
- Zonisamide for Heavy Drinkers With Bipolar Disorder.
Zonisamide; Placebo

Alcohol Use Disorders Clinical Trial using 'Booster session'

Helse Stavanger HF - Recruiting 18 years or older.
- The Effect of an Interdisciplinary 'Booster' Session in Primary Care Following Brief Intervention in Hospitals - a Randomized Clinical Trial.
'Booster session'